Exscientia PLC EXAI
We take great care to ensure that the data presented and summarized in this overview for Exscientia plc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding EXAI
View all-
Sb Global Advisers LTD London, X05.68MShares$27.5 Million3.51% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.59MShares$7.7 Million17.85% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.5MShares$7.24 Million0.01% of portfolio
-
Black Rock Inc. New York, NY785KShares$3.8 Million0.0% of portfolio
-
Css LLC Chicago, IL127KShares$613,6240.06% of portfolio
-
Deka Bank Deutsche Girozentrale80KShares$387,2000.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ27.8KShares$134,3680.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL13.4KShares$64,7150.0% of portfolio
-
Wealth Enhancement Advisory Services, LLC13KShares$63,1030.0% of portfolio
-
Ica Group Wealth Management, LLC Denver, CO600Shares$2,9040.0% of portfolio
Latest Institutional Activity in EXAI
Top Purchases
Top Sells
About EXAI
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Insider Transactions at EXAI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|